3,770
Views
3
CrossRef citations to date
0
Altmetric
Oncology

Trilaciclib and the economic value of multilineage myeloprotection from chemotherapy-induced myelosuppression among patients with extensive-stage small cell lung cancer treated with first-line chemotherapy

ORCID Icon, , , ORCID Icon, , ORCID Icon & show all
Pages 71-83 | Received 22 Jul 2021, Accepted 01 Dec 2021, Published online: 19 Dec 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Articles from other publishers (2)

Shuo Yuan, Dan-Shu Wang, Hui Liu, Sheng-Nan Zhang, Wei-Guang Yang, Meng Lv, Yu-Xue Zhou, Sai-Yang Zhang, Jian Song & Hong-Min Liu. (2023) New drug approvals for 2021: Synthesis and clinical applications. European Journal of Medicinal Chemistry 245, pages 114898.
Crossref
Lodovico Balducci, Claire Falandry & Alan List. (2022) New Advances in Supportive Care: Chemoprotective Agents as Novel Opportunities in Geriatric Oncology. Current Oncology Reports 24:12, pages 1695-1703.
Crossref